Reason reports back from October's Rejuvenation Startup Summit
Fight Aging! - 19-Oct-2022Some really exciting developments with quite a few in clinical trials
Matthias Breugelmans
Life science entrepreneur and CEO of Elastrin Therapeutics
Matthias Breugelmans is a life science entrepreneur and CEO of Elastrin Therapeutics. He has a master’s degree in Pharmaceutical Sciences and a PhD in Medicinal Chemistry. He worked in the pharmaceutical industry at Grünenthal in the Drug Safety department and later as OE / Business Transformation Consultant and Performance and Improvement Lead.
See also: 
Elastrin Therapeutics
- South Carolina-based biotech developing novel therapies
Details last updated 06-Mar-2021
Matthias Breugelmans is also referenced in the following:
Longevity Summit Dublin 2023
17-Aug-2023 to 20-Aug-2023
Club discount available - click here
Event gathering Global Longevity and Rejuvenation community in Dublin with many longevity movement superstars as speakers
Matthias Breugelmans News
Elastrin's novel therapies to reverse age-related vascular damage
Longevity Technology - 04-Mar-2021Advancing technologies for tissue and organ rejuvenation with seed funding from Kizoo
